What’s hot in epilepsy management: Ingrid Scheffer

Clinical practice in epilepsy is being transformed by advances such as the publication of class I evidence for cannabidiol in children, a paediatric neurologist says.

But the specialist, Professor Ingrid Scheffer from the Epilepsy Research Centre at the University of Melbourne’s Florey Institute, cautions that there is a lot of hype about cannabis cures.

Reviewing epilepsy advances in 2017 for the Lancet Neurology, she cited the trial of 120 children with Dravet syndrome in which 20mg per kg per day of plant-extracted,